Isocitrate dehydrogenase-2 (IDH2) Inhibitors
DBCAT004398Pharmacologic class
A DrugBank category of 2 drugs. 2 of them are approved.
- Also known as
- Isocitrate Dehydrogenase 2 Inhibitors
What you can answer from here — as of May 27, 2022
Which targets do Isocitrate dehydrogenase-2 (IDH2) Inhibitors share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account